Science Explorer Back to mapMap

Most cited papers from Procter & Gamble (United Kingdom)

What are the most cited papers from Procter & Gamble (United Kingdom)?

The most cited paper from Procter & Gamble (United Kingdom) is "Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products" (Bob J. Safford, A.M. Api, Christopher L. R. Barratt et al., 2015), with 1,925 citations. Next come "Novel database for exposure to fragrance ingredients in cosmetics and personal care products" (1,867) and "Application of the expanded Creme RIFM consumer exposure model to fragrance ingredients in cosmetic, personal care and air care products" (1,848).

Showing 50 of 60 papers. Every paper with more than 116 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products Bob J. Safford, A.M. Api, Christopher L. R. Barratt et al. · Regulatory Toxicology and Pharmacology 13 Jun 2015 1,925
2 Novel database for exposure to fragrance ingredients in cosmetics and personal care products Damien Comiskey, A.M. Api, Christopher L. R. Barratt et al. · Regulatory Toxicology and Pharmacology 19 May 2015 1,867
3 Application of the expanded Creme RIFM consumer exposure model to fragrance ingredients in cosmetic, personal care and air care products Bob J. Safford, A.M. Api, Christopher L. R. Barratt et al. · Regulatory Toxicology and Pharmacology 28 Feb 2017 1,848
4 Integrating habits and practices data for soaps, cosmetics and air care products into an existing aggregate exposure model Damien Comiskey, A.M. Api, C. B. Barrett et al. · Regulatory Toxicology and Pharmacology 30 May 2017 1,823
5 A strategy for structuring and reporting a read-across prediction of toxicity Terry Wayne Schultz, Patric Amcoff, Elisabet Berggren et al. · Regulatory Toxicology and Pharmacology Open access 21 May 2015 1,589
6 Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids) Lingling Zhang, Yunhong Jiang, Yulong Ding et al. · Journal of Nanoparticle Research 9 Oct 2006 1,494
7 Use of Inhaled Corticosteroids and Risk of Fractures Tjeerd Pieter van Staa, Hubert G. M. Leufkens, Cyrus Cooper · Journal of Bone and Mineral Research Open access Mar 2001 1,314
8 Epidemiology of fractures in England and Wales Tjeerd Pieter van Staa, Elaine Margaret Dennison, H.G.M. Leufkens et al. · Bone Open access Dec 2001 1,142
9 Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome Peter James Whorwell, L. A. Altringer, Jorge G. Morel et al. · The American Journal of Gastroenterology Jul 2006 805
10 Epidemiology of Childhood Fractures in Britain: A Study Using the General Practice Research Database Cyrus Cooper, Elaine Margaret Dennison, H.G.M. Leufkens et al. · Journal of Bone and Mineral Research Open access Dec 2004 709
11 Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate Richard Eastell, Ian P. Barton, RA Hannon et al. · Journal of Bone and Mineral Research Open access Jun 2003 598
12 Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial David M. Reid, Rodney Hughes, Roland Laan et al. · Journal of Bone and Mineral Research Jun 2000 595
13 Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy Tjeerd Pieter van Staa, Roland Laan, Ian P. Barton et al. · Arthritis & Rheumatism Nov 2003 567
14 Use of oral corticosteroids in the United Kingdom Tjeerd Pieter van Staa · QJM Feb 2000 535
15 ZnO nanofluids – A potential antibacterial agent Lingling Zhang, Yulong Ding, Megan Povey et al. · Progress in Natural Science Materials International Open access 21 May 2008 495
16 Mechanistic investigation into antibacterial behaviour of suspensions of ZnO nanoparticles against E. coli Lingling Zhang, Yunhong Jiang, Yulong Ding et al. · Journal of Nanoparticle Research 28 Jul 2009 491
17 Incidence and Natural History of Paget's Disease of Bone in England and Wales Tjeerd Pieter van Staa, Peter L. Selby, Hubert G. M. Leufkens et al. · Journal of Bone and Mineral Research Open access Mar 2002 369
18 Stratum Corneum Moisturization at the Molecular Level: An Update in Relation to the Dry Skin Cycle Anthony Vincent Rawlings, Paul J. Matts · Journal of Investigative Dermatology Open access Jun 2005 357
19 Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients A.M. Api, David Arthur Basketter, Peter A. Cadby et al. · Regulatory Toxicology and Pharmacology 27 Nov 2007 334
20 Evidence based guidelines for the prevention, identification, and management of occupational asthma Paul J Nicholson, Paul Cullinan, Anthony J. Newman Taylor et al. · Occupational and Environmental Medicine Open access 18 Apr 2005 320
21 Evidence for increased bone resorption in patients with progressive knee osteoarthritis: Longitudinal results from the Chingford study Paolo U. Bettica, Gary A. Cline, Deborah J Hart et al. · Arthritis & Rheumatism Dec 2002 300
22 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study Tjeerd Pieter van Staa, T Card, R F Logan et al. · Gut Open access 30 Jun 2005 288
23 Environmental fate of Triclosan in the River Aire Basin, UK Darius Sabaliūnas, Simon Webb, Armin Hauk et al. · Water Research 3 Jun 2003 278
24 Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines Richard F. Logan, T P van Staa · Gut Open access 11 Sep 2003 262
25 Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience☆☆This study was sponsored by Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, and Aventis Pharma, Bridgewater, New Jersey. O. H. Sørensen, Gordon M. Crawford, Hindrik Mulder et al. · Bone Feb 2003 255
26 The EC/HO international validation study on alternatives to the draize eye irritation test Michael Balls, Philip A. Botham, Leon H. Bruner et al. · Toxicology in Vitro Dec 1995 255
27 Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women Susan R. Davis, Marius J. van der Mooren, Rik H. W. van Lunsen et al. · Menopause The Journal of The North American Menopause Society May 2006 251
28 Inflammatory bowel disease and the risk of fracture Tjeerd Pieter van Staa, Cyrus Cooper, L S Brusse et al. · Gastroenterology Open access Dec 2003 250
29 Importance of Water-Volume on the Release of Microplastic Fibers from Laundry Max R. Kelly, Neil J. Lant, Martyn Kurr et al. · Environmental Science & Technology Open access 28 Aug 2019 241
30 Children and the Risk of Fractures Caused by Oral Corticosteroids Tjeerd Pieter van Staa, Cyrus Cooper, HGM Leufkens et al. · Journal of Bone and Mineral Research Open access May 2003 233
31 Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis J. Timothy Harrington, L.-G. Ste-Marie, Maria Luisa Brandi et al. · Calcified Tissue International 20 Feb 2004 224
32 Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydrationin vivo Jonathan M. Crowther, Anke Sieg, Peter Blenkiron et al. · British Journal of Dermatology Jun 2008 221
33 A proposed eye irritation testing strategy to reduce and replace in vivo studies using Bottom–Up and Top–Down approaches Laurie Scott et al. · Toxicology in Vitro Jun 2009 215
34 Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study Piotr Krzeski, Chris Buckland‐Wright, Géza Bálint et al. · Arthritis Research & Therapy Open access 24 Oct 2007 205
35 Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study Steven Boonen, ERIC S. ORWOLL, Dietrich Wenderoth et al. · Journal of Bone and Mineral Research 2 Dec 2008 195
36 Scaling of discrete element model parameters for cohesionless and cohesive solid Subhash C. Thakur, Jin Yeam Ooi, Hossein Ahmadian · Powder Technology Open access 14 Jun 2015 180
37 5-aminosalicylic acids and the risk of renal disease: A large British epidemiologic study☆ Tjeerd Pieter van Staa, Simon P.L. Travis, Hubert G. M. Leufkens et al. · Gastroenterology Open access Jun 2004 172
38 Practical Aspects of the Validation of Toxicity Test Procedures Michael Balls, Bas J. Blaauboer, Julia H. Fentem et al. · Alternatives to Laboratory Animals 1995 169
39 Testosterone treatment of HSDD in naturally menopausal women: the ADORE study Nicholas Panay, Farook Al‐Azzawi, Céline Bouchard et al. · Climacteric 19 Feb 2010 169
40 Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis William J. Sandborn, Jarosław Reguła, Brian G. Feagan et al. · Gastroenterology 19 Sep 2009 169
41 European consumer exposure to cosmetic products, a framework for conducting population exposure assessments Barbara M. Hall, S. Tozer, Bob J. Safford et al. · Food and Chemical Toxicology 17 Jun 2007 162
42 The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results Tjeerd Pieter van Staa, Lucien Abenhaim, Cyrus Cooper et al. · Pharmacoepidemiology and Drug Safety 2000 160
43 Visible skin condition and perception of human facial appearance Nadine Samson, Bernhard Fink, Paul J. Matts · International Journal of Cosmetic Science 3 Nov 2009 159
44 The international validation of a fixed-dose procedure as an alternative to the classical LD50 test Marianne J. Van Den Heuvel, David G. Clark, Robin J. Fielder et al. · Food and Chemical Toxicology 1990 158
45 Evidence‐based guidelines for the prevention, identification and management of occupational contact dermatitis and urticaria* Paul J Nicholson, Diane Llewellyn, John S. C. English et al. · Contact Dermatitis 9 Sep 2010 157
46 Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies Steven Boonen, Roland Laan, Ian P. Barton et al. · Osteoporosis International ReviewOpen access 28 Jun 2005 156
47 Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator Paul Dorian, Martin Borggrefe, Hussein R. Al‐Khalidi et al. · Circulation Open access 9 Nov 2004 155
48 Eye irritation: Reference chemicals data bank D.M. Bagley, Philip A. Botham, J.R. Gardner et al. · Toxicology in Vitro Nov 1992 148
49 Pyrrolizidine alkaloids in food and phytomedicine: Occurrence, exposure, toxicity, mechanisms, and risk assessment - A review Dieter Schrenk, Lan Gao, Ge Lin et al. · Food and Chemical Toxicology Open access 2 Jan 2020 141
50 A summary report of the COLIPA international validation study on alternatives to the draize rabbit eye irritation test Paul Brantom et al. · Toxicology in Vitro Feb 1997 141

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.